Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations

References

• Kopp AF, Mortele KJ, Cho YD, Palkowitsch P, Bettmann MA, Claussen CD. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients. Acta Radiol 2008;49:902–11.
   PubMed Web of Science ®Google Scholar
• Morcos SK. Review article: Acute serious and fatal reactions to contrast media: our current understanding. Br J Radiol 2005;78:686–93.
   PubMed Web of Science ®Google Scholar
• Idée JM, Pines E, Prigent P, Corot C. Allergy-like reactions to iodinated contrast agents. A critical analysis. Fundam Clin Pharmacol 2005;19:263–81.
   Google Scholar
• Maddox TG. Adverse reactions to contrast material: recognition, prevention, and treatment. Am Fam Physician 2002;66:1229–34.
   Web of Science ®Google Scholar
• Davidson C, Stacul F, McCullough PA, Tumlin J, Adam A, Lameire N, . Contrast medium use. Am J Cardiol 2006;98(6 Suppl 1):42–58.
   Google Scholar
• Liccardi G, Lobefalo G, Di Florio E, Di Iorio C, Occhiochiuso L, Romano L, . Strategies for the prevention of asthmatic, anaphylactic and anaphylactoid reactions during the administration of anesthetics and/or contrast media. J Investig Allergol Clin Immunol 2008;18:1–11.
   PubMed Web of Science ®Google Scholar
• Webb JA, Stacul F, Thomsen HS, Morcos SK. Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 2003;13:181–4.
   PubMed Web of Science ®Google Scholar
• DeAngelis CD, Fontanarosa PB. Prescription drugs, products liability, and preemption of tort litigation. JAMA 2008;300:1939–41.
   Google Scholar
• Petersein J, Peters CR, Wolf M, Hamm B. Results of the safety and efficacy of iobitridol in more than 61,000 patients. Eur Radiol 2003;13:2006–11.
   Google Scholar
• Munechika H, Hiramatsu Y, Kudo S, Sugimura K, Hamada C, Yamaguchi K, . A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol 2003;13:185–94.
   PubMed Web of Science ®Google Scholar
• Mortelé KJ, Oliva MR, Ondategui S, Ros PR, Silverman SG. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. Am J Roentgenol 2005;184:31–4.
   PubMed Web of Science ®Google Scholar
• Lewis JA. Post-marketing surveillance: how many patients? Trends Pharmacol Sci 1981;2:93–4.
   Web of Science ®Google Scholar
• Vogl TJ, Honold E, Wolf M, Mohajeri H, Hammerstingl R. Safety of iobitridol in the general population and at-risk patients. Eur Radiol 2006;16:1288–97.
   Google Scholar
• Wendt-Nordahl G, Rotert H, Trojan L, Michel MS, Peters CR, Alken P, . Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients. Med Princ Pract 2006;15:358–61.
   Google Scholar
• Sutton AG, Finn P, Grech ED, Hall JA, Stewart MJ, Davies A, . Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterisation. Am Heart J 2001;141:677–83.
   PubMedGoogle Scholar
• Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990;175:621–8.
   PubMed Web of Science ®Google Scholar
• Namasivayam S, Kalra MK, Torres WE, Small WC. Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol 2006;12:210–15.
   PubMedGoogle Scholar
• Gomi T, Nagamoto M, Hasegawa M, Katoh A, Sugiyama M, Murata N, . Are there any differences in acute adverse reactions among five low-osmolar non-ionic iodinated contrast media? Eur Radiol 2010;20:1631–5.
   Google Scholar
• Enright T, Chua-Lim A, Duda E, Lim DT. The role of a documented allergic profile as a risk factor for radiographic contrast media reaction. Ann Allergy 1989;62:302–5.
   Google Scholar
• Brockow K, Romano A, Aberer W, Bircher AJ, Barbaud A, Bonadonna P, . Skin testing in patients with hypersensitivity reactions to iodinated contrast media – a European multicentre study. Allergy 2009;64:234–41.
   PubMed Web of Science ®Google Scholar
• Tramer MR, von Elm E, Loubeyre P, Hauser C. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. Br Med J 2006;333:675.
   PubMed Web of Science ®Google Scholar
• Klow NE, Levorstad K, Berg KJ, Brodahl U, Endresen K, Kristoffersen DT, . Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects. Acta Radiol 1993;34:72–7.
   PubMedGoogle Scholar
• Hill JA, Cohen MB, Kou WH, Mancini GB, Mansour M, Fountaine H, . Iodixanol, a new isosmotic nonionic contrast agent compared with iohexol in cardiac angiography. Am J Cardiol 1994;74:57–63.
   PubMedGoogle Scholar
• Tveit K, Bolz KD, Bolstad B, Haugland T, Berg KJ, Skjaerpe T, . Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml. Acta Radiol 1994;35: 614–18.
   PubMedGoogle Scholar
• Pugh ND, Sissons GR, Ruttley MS, Berg KJ, Nossen JO, Eide H. Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide. Clin Radiol 1993;47:96–9.
   PubMedGoogle Scholar
• Justesen P, Downes M, Grynne BH, Lang H, Rasch W, Seim E. Injection-associated pain in femoral arteriography: a European multicentre study comparing safety, tolerability, and efficacy of iodixanol and iopromide. Cardiovasc Intervent Radiol 1997;20:251–6.
   PubMedGoogle Scholar
• Verow P, Nossen JO, Sheppick A, Kjaersgaard P. A comparison of iodixanol with iopamidol in aorto-femoral angiography. Br J Radiol 1995;68:973–8.
   Google Scholar
• Palmers Y, De Greef D, Grynne BH, Smits J, Put E. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography. Eur J Radiol 1993;17:203–9.
   PubMedGoogle Scholar
• Manke C, Marcus C, Page A, Puey J, Batakis O, Fog A. Pain in femoral arteriography. A double-blind, randomised, clinical study comparing safety and efficacy of the iso-osmolar iodixanol 270 mgI/ml and the low-osmolar iomeprol 300 mgI/ml in 9 European centres. Acta Radiol 2003;44:590–6.
   Google Scholar
• Thorstensen O, Albrechtsson U, Calissendorff B, Larusdottir H, Norgren L, Tengvar M, . Iodixanol in femoral arteriography. A randomised, double-blind, phase III, parallel study with iodixanol 270 mg I/ml and iohexol 300 mg I/ml. Acta Radiol 1994;35:629–31.
   Google Scholar
• Skehan SJ, Rasmussen F, Gibney RG, Lindequist S, Moller-Nielsen S, Svaland MG, . A comparison of a non-ionic dimer, iodixanol with a non-ionic monomer, iohexol in low dose intravenous urography. Br J Radiol 1998;71:910–17.
   PubMedGoogle Scholar
• MacLennan A, Machan L. A comparative, randomised, double-blind crossover trial of iodixanol 270 and iohexol 300 in femoral arteriography. CIRSE 1997;(Suppl 1):89 Abstract no. 167.
   Google Scholar